)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
CelLBxHealth
CelLBxHealth (CLBX) investor relations material
CelLBxHealth Q3 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 TU earnings summary21 Oct, 2026
Executive summary
Q3 new business rose threefold YoY to £0.3m; 9M cash operating loss fell 60% to £4.0m, while FY 2026 revenue guidance was revised to ~£1.8m due to timing effects from operational realignment.
FY 2027 revenue is expected to reach £3.0m–£4.0m, supported by stronger commercial momentum, an expanding pipeline and operational improvements.
Financial highlights
Q3 revenue booked was £0.2m; new business secured was £0.3m versus £0.1m in Q3 2025.
9M cash operating loss decreased 60% YoY to £4.0m from £9.7m; cash and cash equivalents were £1.4m at 30 September 2026.
FY 2026 revenue is expected at ~£1.8m, up 29% YoY from £1.4m in FY 2025; a further £0.1m of business was secured in early October.
Outlook and guidance
Q4 investment in growth, product and service optimisation, and new product development is expected to raise average monthly cash expenditure by £0.1m from Q3's £0.4m cash burn.
Following receipt of the anticipated £0.8m R&D tax credit, cash runway is expected to extend through Q1 2027.
FY 2027 revenue guidance is £3.0m–£4.0m, reflecting anticipated commercial momentum, pipeline expansion and benefits of 2026 operational improvements.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from CelLBxHealth
- Q2 revenue doubled and cost base was cut, but funding beyond Q2 2027 remains uncertain.CLBX
H1 2026 - Restructuring and key partnerships set the stage for strong revenue growth and EBITDA targets.CLBXH2 2025
- Restructuring and cost cuts drive a projected 50% revenue increase for FY 2026.CLBXQ1 2026 TU
- FY2025 revenue was £1.4M, with cost cuts and partnerships driving targeted FY26 growth.CLBXQ4 2025 TU
- Fundraise, restructuring, and partnerships drive CTC diagnostics growth and target 2028 profitability.CLBXInvestor Update
- Revenue fell to £0.8m, but cost controls and new contracts support growth and cash runway into 2026.CLBXH1 2025
- Large pharma contracts and cost controls set the stage for growth and cashflow positive trading by 2026.CLBXH1 2024
- Revenue doubled and losses narrowed as commercial momentum builds and cash runway extends.CLBXH2 2023
- Patented blood test isolates living tumor cells, enabling earlier, more precise cancer care.CLBXEmerging Growth Conference 79
CelLBxHealth
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage